1Brange J, Voluned A. Insulin analogs with improved pharmacokinetic profiles. Adv Drug Delivery Rev,1999, 35:307-335.
2Brems DN, Alter LA, Beckage ML, et al. Altering the association properties of insulin by amino acid replacement. Protein Eng, 1992,5: 527 - 533.
3Drejer K. The bioactivity of insulin analogues from in vitro receptor binding to vivo glucose uptake. Diabetes Metab Reva, 1992, 8:259- 286.
4Rosenfalck A ,Thorsby P, Kjems L, et al. Improved postprandial glycogenic controls with insular apart in type 2 diabetic patients treated with insulin. Acta Diabetolog, 2000, 31:41-46.
5Home P, Lindholm A, Rijs A. Insulin vs human insulin in the management of long - term blood glucese control in type 1 diabetes mellitus: a randomized controlled. Diabetic Med, 2000, 17:762-770.
6Mortensen H , Lindholm A, Olsen B, et al. Rapid appearance and onset of action of insulin apart in pediatric subjects with typoldiabtes.Eur J Pediatric, 2000, 159:483 -488.
2Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care ,2001,24 : 89-94.
3Bruttomesso D , Pianta A, et al. Restoration of early rise in plesma insulin levels improve the glucose tolerance of type 2 diabetes patients. Diabetes, 1999 ,48:99-105.
4Monnier L, Lapinski H,Colette C. Contributions of Fasting and Postprandial Plasma Gluose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic Patients. Diabetes care, 2003,26(3) :881-885.
5Mortensen HB ,Lindholm A, Olsen BS ,et al. Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes. Eur J Pediatr,2000,159:483-488.
6Lindholm A ,Jacobsen LV . Clinical pharmacokinetics and pharmacodynamics of insulin aspart. Clin Pharmacokinet ,2001,40:641-659.
